If a patient does not respond to the first-line therapy (amitriptyline, cyproheptadine, and/or propranolol) the following options should be considered: (1) presence of persisting triggers (e.g., psychological stressors) and comorbid conditions (e.g., anxiety, POTS) or missed underlying disorders (e.g., hydronephrosis, chronic sinusitis, acute appendicitis, intestinal malrotation with volvulus, CNS tumors, metabolic crises) and toxic exposure (e.g., cannabis)
Medicare will notify you after the request is reviewed
Who can use GLP-1 for Weight Loss
The weakening of this barrier leads to increased intestinal permeability, or what we call Leaky Gut Syndrome
The 2 oz jar delivers deep hydration without a heavy feel, making this cream suitable for a wide range of skin types
Her work focuses on the intersection of biotechnology, health, and international relations, with a